Literature DB >> 7219466

Steroid antiemesis may be harmful.

M Haid.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7219466     DOI： 10.1056/NEJM198105143042015

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer.

Authors:  Vladimir Djedovic; Yoo-Young Lee; Alexandra Kollara; Taymaa May; Theodore J Brown
Journal:  Horm Cancer       Date:  2018-01-08       Impact factor: 3.869

2.  Single high-dose dexamethasone improves the effect of ondansetron on acute chemotherapy-induced nausea and vomiting but impairs the control of delayed symptoms.

Authors:  C Peterson; T J Hursti; S Börjeson; E Avall-Lundqvist; M Fredrikson; C J Fürst; H Lomberg; G Steineck
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

3.  High-dose dexamethasone for prevention of cis-platin-induced vomiting.

Authors:  M S Aapro; D S Alberts
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Glucocorticoids attenuate taste aversions produced by toxins in rats.

Authors:  S Revusky; G M Martin
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

5.  Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy.

Authors:  J Herrstedt; T C Sigsgaard; H A Nielsen; J Handberg; S W Langer; S Ottesen; P Dombernowsky
Journal:  Support Care Cancer       Date:  2006-11-09       Impact factor: 3.359

6.  Role of dexamethasone dosage in combination with 5-HT3 antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting.

Authors:  K Münstedt; H Müller; E Blauth-Eckmeyer; K Stenger; M Zygmunt; H Vahrson
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

Review 7.  Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments.

Authors:  Nora Sundahl; Dorien Clarisse; Marc Bracke; Fritz Offner; Wim Vanden Berghe; Ilse M Beck
Journal:  Oncoscience       Date:  2016-07-27

8.  Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer.

Authors:  Chengwen Zhang; Armin Kolb; Peter Büchler; Andrew C B Cato; Jürgen Mattern; Werner Rittgen; Lutz Edler; Klaus-Michael Debatin; Markus W Büchler; Helmut Friess; Ingrid Herr
Journal:  BMC Cancer       Date:  2006-03-15       Impact factor: 4.430

9.  Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1.

Authors:  Li Liu; Ewa Aleksandrowicz; Frank Schönsiegel; Daniel Gröner; Nathalie Bauer; Clifford C Nwaeburu; Zhefu Zhao; Jury Gladkich; Torsten Hoppe-Tichy; Eitan Yefenof; Thilo Hackert; Oliver Strobel; Ingrid Herr
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.